Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified induction course: a solution to side-effects?

P Bassi1, R Spinadin, R Carando

  • 1Department of Urology, University of Padova, Padova, Italy. bassipf@ux1.unipd.it

European Urology
|November 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Skeletal and Airway Changes Between Subjects with Class II Malocclusion Treated with Functional Therapy in the Pre-Pubertal and Pubertal Phases.

European journal of paediatric dentistry·2025
Same author

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells.

Frontiers in oncology·2025
Same author

Cascade of care for TB infection in persons newly diagnosed with HIV in Italy.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Non-cholera Vibrio spp. invasive infections in the summer following May 2023 flood disaster in Romagna, Italy: a case series.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

Reduction in broad-spectrum antimicrobial prescriptions by primary care pediatricians following a multifaceted antimicrobial stewardship program.

Frontiers in pediatrics·2023
Same author

Concept Development of an On-Chip PET System.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
See all related articles

Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer can cause side-effects. Researchers explored low-dose and slow-rate BCG regimens to reduce side-effects without compromising treatment efficacy.

Area of Science:

  • Oncology
  • Urology
  • Immunotherapy

Background:

  • Intravesical Bacillus Calmette-Guérin (BCG) is a standard treatment for superficial bladder cancer.
  • Treatment-limiting side-effects frequently occur during BCG immunotherapy.
  • These side-effects can lead to treatment delays or interruptions, potentially reducing efficacy.

Purpose of the Study:

  • To investigate strategies for reducing BCG-related side-effects in superficial bladder cancer treatment.
  • To evaluate if modified BCG immunotherapy regimens can maintain therapeutic efficacy while minimizing adverse events.

Main Methods:

  • Phase II and III clinical trials were conducted.
  • Two modified BCG immunotherapy regimens were assessed: a low-dose regimen and a slow-rate regimen.

Related Experiment Videos

  • The study aimed to reduce BCG side-effects without compromising treatment efficacy.

    • Main Results:

    • The study investigated two specific approaches to BCG immunotherapy: reducing the dose per instillation ('low-dose' regimen) and delaying the interval between instillations ('slow-rate' regimen).
    • These trials were designed to assess the feasibility of mitigating BCG-related side-effects while preserving the treatment's effectiveness.

    Conclusions:

    • Modified BCG immunotherapy regimens, such as low-dose or slow-rate instillation schedules, may offer a way to manage side-effects.
    • Further research is needed to confirm if these modified regimens can maintain the efficacy of BCG immunotherapy for superficial bladder cancer.